← Leaderboards
Michelle Ann O'Malley
Biodesy, Inc
$270,336
Attributed
$540,672
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $279.7K · FY2019–20$500K$375K$250K$125K$0
'19
'20
Funding mix
By agency
NIH$540,672 · 1
By mechanism
R43$540,672 · 1
Top collaborators
- Ben Moree2 shared
Others in their field
Other Emerging Leaders on “Adora2a Gene”
- Rebecca Diane Levit · Emory University$2,228,802
- Edward Ray Lyman · University Of Delaware$2,196,194
- Matthew Thomas Eddy · University Of Florida$2,157,882
- Robert Koehler Abbott · University Of Texas Med Br Galveston$1,886,400
- Elisabetta Mueller · Diabetes, Digestive, Kidney Diseases$1,394,782
- Rajan Lamichhane · University Of Tennessee Knoxville$1,193,093
Research focus
Adora2a GeneAnimal ModelAffinityAvidinBaseBindingAssay DevelopmentBiologicalBiophysical ToolsBiophysicsBiotinBrainCellsChimeric ProteinsCollectionBiochemicalConsumptionCouplingC-TerminalCysteineDesignDetergentsDevicesDocking
Grant awards (2)
SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes$260,927
R43 · FY2020 · MH
SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes$279,745
R43 · FY2019 · MH